Trademark: 97301667
Status Date
Thursday, December 14, 2023
Filing Date
Tuesday, March 8, 2022
Published for Opposition
Tuesday, May 2, 2023
5 pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors
42 research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Dec 14, 2023
Sou Extension 1 Granted
Dec 14, 2023
Sou Extension 1 Filed
Dec 14, 2023
Sou Teas Extension Received
Jun 27, 2023
Noa E-Mailed - Sou Required From Applicant
May 2, 2023
Official Gazette Publication Confirmation E-Mailed
May 2, 2023
Published For Opposition
Apr 12, 2023
Notification Of Notice Of Publication E-Mailed
Mar 24, 2023
Approved For Pub - Principal Register
Mar 7, 2023
Teas/Email Correspondence Entered
Mar 6, 2023
Correspondence Received In Law Office
Mar 6, 2023
Teas Response To Office Action Received
Sep 29, 2022
Notification Of Non-Final Action E-Mailed
Sep 29, 2022
Non-Final Action E-Mailed
Sep 29, 2022
Non-Final Action Written
Sep 28, 2022
Assigned To Examiner
Mar 14, 2022
New Application Office Supplied Data Entered
Mar 11, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
